Targeted therapy offers hope for chronic myeloid leukemia cure Chest closure aid is just superSternotomy patients experience less pain and disability when ‘Kryptonite’ adhesive is used Conference to tackle "medication mysteries" Saskatchewan pharmacists are targets for the two-day “Solving the Medication Reconciliation Mystery” conference Dec 2-3 in Saskatoon. Guidelines highlight cutting-edge AF treatments Role of recently approved drugs outlined in new atrial fibrillation recommendations Jaw defects respond to parathyroid hormone Osteoporosis drug may have a future in filling the need for a treatment for periodontal disease Is brand name best for bisphosphonates? Generics may dissolve too quickly, increasing adverse events Nitroglycerin gives blast to bone strength Heart drug may have a future in osteoporosis treatment, but headaches are an obstacle Write, then dispense? Two MDs go head to head debating the pros and cons of pharmacist prescribing LETTER: Pharmacists have little leeway on ‘no subs’ Men get osteoporosis, too Researcher advises how to avoid BMD measurement pitfalls in older men Do pharmacists need a union? A majority say yes, according to poll. New single-dose azithromycin formulation for RTIs Pfizer is introducing Zmax SR, a product that provides a single 2 g dose of azithromycin as sustained-release granules for oral suspension. First Previous 921 922 923 924 925 Next Last
